Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005;1(2):159-67.
doi: 10.1385/SCR:1:2:159.

Cell replacement therapy and the evasion of destructive immunity

Paul J Fairchild  1 , Nathan J Robertson, Siân Cartland, Kathleen F Nolan, Herman Waldmann
Affiliations
Review

Cell replacement therapy and the evasion of destructive immunity

Paul J Fairchild et al. Stem Cell Rev. 2005.

Abstract

The potential of human embryonic stem (ES) cells to meet the growing demand for cell types and tissues for the treatment of chronic and degenerative diseases has been widely acclaimed. Nevertheless, their use in cell replacement therapy poses a number of significant challenges, not least of which is their subsequent rejection by the recipient's immune system. Here we explore the extent of the immunological barriers encountered and evaluate the potential of different approaches to overcoming these issues of which somatic nuclear transfer (SNT) and the induction of transplanation tolerance are currently the most promising.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Immunity. 2003 Oct;19(4):503-14 - PubMed
    1. Curr Opin Immunol. 2002 Oct;14(5):601-5 - PubMed
    1. Curr Biol. 1998 Aug 27;8(17):971-4 - PubMed
    1. J Exp Med. 1982 Jan 1;155(1):31-41 - PubMed
    1. Methods Enzymol. 2003;365:169-86 - PubMed

LinkOut - more resources